Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Experiences in Natural life Protection: Individual Progressives' Excursions - 2ADHD drugs work, but not the way experts thought
- 3Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- 4The Rhythms of the Street: Shipping's Tune in the Economy's Symphony
- 5Vote in favor of your #1 Kind of Cap
- Dozens injured in Russia after train crashes, overturns
- NASA's Artemis astronauts enter final preparations for Moon mission
- 10 Demonstrated Tips to Boost Your New Android Cell phone: A Thorough Aide
- Remote Headphones: Upgrade Your Sound Insight
- Most loved Seared Chicken: Which Chain Rules?
- What to know about King Charles III's cancer treatment and his message to the public
- What's changing about healthcare in 2026 — Medicare, Medicaid, ACA, premiums, and enrollment deadlines
- The Iconic, Instantly Recognizable Plastic Chair That's Known All Around The World
- Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
